Sự gia tăng phân hủy proteasome của ức chế kinase phụ thuộc cyclin p27 liên quan đến tỷ lệ sống sót tổng thể giảm ở lymphoma tế bào vỏ

Nakamura, 1997, Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma., Leukemia., 11(suppl 3), 536 de Boer, 1997, Bcl-1/cyclin D1 in malignant lymphoma., Ann Oncol., 8(suppl 2), 109, 10.1093/annonc/8.suppl_2.S109 Yatabe, 1996, Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma: a distinct molecular pathologic entity., Am J Surg Pathol., 20, 1110, 10.1097/00000478-199609000-00009 Loyson, 1996, Mantle cell lymphoma: a morphological, immunohistochemical and molecular genetic study., Pathol Res Pract., 192, 781, 10.1016/S0344-0338(96)80051-3 Raffeld, 1991, bcl-1, t(11;14), and mantle cell-derived lymphomas., Blood., 78, 259, 10.1182/blood.V78.2.259.bloodjournal782259 De Wolf-Peeters, 1994, Mantle-cell lymphoma., Ann Oncol., 5(suppl 1), 35, 10.1093/annonc/5.suppl_1.S35 Bosch, 1994, PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma., Blood., 84, 2726, 10.1182/blood.V84.8.2726.2726 de Boer, 1995, Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma., Blood., 86, 2715, 10.1182/blood.V86.7.2715.2715 Ott, 1996, bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma., J Pathol., 179, 238, 10.1002/(SICI)1096-9896(199607)179:3<238::AID-PATH566>3.0.CO;2-W Kumar, 1996, bcl-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis., Am J Clin Pathol., 105, 737, 10.1093/ajcp/105.6.737 The Non-Hodgkin's Lymphoma Classification Project, 1997, A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma., Blood., 89, 3909, 10.1182/blood.V89.11.3909 Lardelli, 1990, Lymphocytic lymphoma of intermediate differentiation: morphologic and immunophenotypic spectrum and clinical correlations., Am J Surg Pathol., 14, 752, 10.1097/00000478-199008000-00007 Duggan, 1990, Mantle zone lymphoma: a clinicopathologic study of 22 cases., Cancer., 66, 522, 10.1002/1097-0142(19900801)66:3<522::AID-CNCR2820660320>3.0.CO;2-4 Fisher, 1995, A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study., Blood., 85, 1075, 10.1182/blood.V85.4.1075.bloodjournal8541075 Fisher, 1996, Mantle-cell lymphoma: classification and therapeutic implications., Ann Oncol., 7(suppl 6), S35, 10.1093/annonc/7.suppl_6.S35 Swerdlow, 1996, The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements., Am J Surg Pathol., 20, 627, 10.1097/00000478-199605000-00009 Weisenburger, 1996, Mantle cell lymphoma: an entity comes of age., Blood., 87, 4483, 10.1182/blood.V87.11.4483.bloodjournal87114483 Zoldan, 1996, Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome., Br J Haematol., 93, 475, 10.1046/j.1365-2141.1996.5421085.x Soslow, 1997, BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma., Mod Pathol., 10, 810 Harris, 1994, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group., Blood., 84, 1361, 10.1182/blood.V84.5.1361.1361 Ott, 1994, The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices., Histopathology., 24, 329, 10.1111/j.1365-2559.1994.tb00533.x Ott, 1997, Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones., Blood., 89, 1421, 10.1182/blood.V89.4.1421 Greiner, 1996, p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis., Blood., 87, 4302, 10.1182/blood.V87.10.4302.bloodjournal87104302 Hernandez, 1996, p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas., Blood., 87, 3351, 10.1182/blood.V87.8.3351.bloodjournal8783351 Louie, 1995, p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)., Blood., 86, 2892, 10.1182/blood.V86.8.2892.2892 Williams, 1997, Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia., Ann Oncol., 8(suppl 2), 71, 10.1093/annonc/8.suppl_2.S71 Pinyol, 1997, Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas., Blood., 89, 272, 10.1182/blood.V89.1.272 Hunter, 1994, Cyclins and cancer, II: cyclin D and CDK inhibitors come of age., Cell., 79, 573, 10.1016/0092-8674(94)90543-6 Yamasaki, 1998, Growth regulation by the E2F and DP transcription factor families., Results Probl Cell Differ., 22, 199, 10.1007/978-3-540-69686-5_9 Nevins, 1997, Functional analysis of E2F transcription factor., Methods Enzymol., 283, 205, 10.1016/S0076-6879(97)83017-0 el-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression., Cell., 75, 817, 10.1016/0092-8674(93)90500-P Dulic, 1994, p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest., Cell., 76, 1013, 10.1016/0092-8674(94)90379-4 Sherr, 1995, Inhibitors of mammalian G1 cyclin-dependent kinases., Genes Dev., 9, 1149, 10.1101/gad.9.10.1149 Yang, 1998, Low p27 expression predicts poor disease-free survival in patients with prostate cancer., J Urol., 159, 941, 10.1016/S0022-5347(01)63776-5 Esposito, 1997, Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer., Cancer Res., 57, 3381 Loda, 1997, Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas., Nat Med., 3, 231, 10.1038/nm0297-231 Tan, 1997, The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas., Cancer Res., 57, 1259 Pittaluga, 1998, Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes., Br J Haematol., 102, 1301, 10.1046/j.1365-2141.1998.00907.x Pittaluga, 1995, Mantle cell lymphoma: a clinicopathological study of 55 cases., Histopathology., 26, 17, 10.1111/j.1365-2559.1995.tb00615.x Helin, 1993, Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein., Mol Cell Biol., 13, 6501, 10.1128/MCB.13.10.6501 Helin, 1993, Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation., Genes Dev., 7, 1850, 10.1101/gad.7.10.1850 Chilosi, 1994, Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease., Blood., 84, 4295, 10.1182/blood.V84.12.4295.bloodjournal84124295 Yee, 1996, Molecular characterization of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease., Blood., 87, 1081, 10.1182/blood.V87.3.1081.bloodjournal8731081 Pagano, 1992, Association of cdk2 kinase with the transcription factor E2F during S phase., Science., 255, 1144, 10.1126/science.1312258 Meyer, 1986, Antibodies directed against ubiquitin inhibit high affinity [3H]choline uptake in rat cerebral cortical synaptosomes., J Biol Chem., 261, 14,365, 10.1016/S0021-9258(18)66877-2 Gussow, 1987, The human beta 2-microglobulin gene: primary structure and definition of the transcriptional unit., J Immunol., 139, 3132, 10.4049/jimmunol.139.9.3132 Pagano, 1995, Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27., Science., 269, 682, 10.1126/science.7624798 Haas, 1981, Hemin inhibits ATP-dependent ubiquitin-dependent proteolysis: role of hemin in regulating ubiquitin conjugate degradation., Proc Natl Acad Sci U S A., 78, 6845, 10.1073/pnas.78.11.6845 Fero, 1998, The murine gene p27Kip1 is haplo-insufficient for tumour suppression., Nature., 396, 177, 10.1038/24179 Quintanilla-Martinez, 1998, Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor., Am J Pathol., 153, 175, 10.1016/S0002-9440(10)65558-7 Field, 1996, E2F-1 functions in mice to promote apoptosis and suppress proliferation., Cell., 85, 549, 10.1016/S0092-8674(00)81255-6 Yamasaki, 1996, Tumor induction and tissue atrophy in mice lacking E2F-1., Cell., 85, 537, 10.1016/S0092-8674(00)81254-4 Lai, 1998, Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases., Mod Pathol., 11, 457 Lai, 1998, Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf- 1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity., Mod Pathol., 11, 642 Cordon-Cardo, 1998, Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma., J Natl Cancer Inst., 90, 1284, 10.1093/jnci/90.17.1284 Hengst, 1996, Translational control of p27Kip1 accumulation during the cell cycle., Science., 271, 1861, 10.1126/science.271.5257.1861 Millard, 1997, Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest., J Biol Chem., 272, 7093, 10.1074/jbc.272.11.7093 Morosetti, 1995, Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma., Blood., 86, 1924, 10.1182/blood.V86.5.1924.bloodjournal8651924 Spirin, 1996, p27/Kip1 mutation found in breast cancer., Cancer Res., 56, 2400 Stegmaier, 1995, Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood., Blood., 86, 38, 10.1182/blood.V86.1.38.bloodjournal86138 Stegmaier, 1996, Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia., Cancer Res., 56, 1413 Pietenpol, 1995, Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias., Cancer Res., 55, 1206 Nakayama, 1996, Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors., Cell., 85, 707, 10.1016/S0092-8674(00)81237-4 Kiyokawa, 1996, Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)., Cell., 85, 721, 10.1016/S0092-8674(00)81238-6 Fero, 1996, A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice., Cell., 85, 733, 10.1016/S0092-8674(00)81239-8 Park, 1999, p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice., Proc Natl Acad Sci U S A., 96, 6382, 10.1073/pnas.96.11.6382